Member Info for trytryandagain

https://www.proactiveinvestors.co.uk/companies/news/933491/iq-ai-trebles-in-value-after-impressive-run-of-updates-933491.html

Sold all my oil stocks and spent two hours quoting and buying 300,000 AQAI shared added today. .6% total for me now :-) Very happy boy.

To be honest, they can do as they wish.. those that hold will as always get the best rewards long term if the business lives up to its potential, and here I am a firm believer it will.

Great to cement last week's rise. Exactly what we needed, so excited for every RNS now... except the speeding tickets!

Almost as though the MMs ask for it as we were all holding strong and encouraging others lol

This is the exact reason I haven't traded one share I would have to need up in the same place or worse off trying to get them all back.

How do you load up there's nothing available lol

I do have to wonder where the MM's are going to get shares from today. LTH that wanted a little profit were out last week and many traders cleared Thursday and Friday. It's going to be an interesting watch today for sure.

17p already showing to buy on IG, bet it goes NT

Possibly another day of NT and speeding tickets!

That 20k from initial installation is a very interesting number we can presume then that installation costs 200k or there abouts... thoughts?

I am hoping for another nice consolidation day, I wouldn't say no to a solid 3-5% blue end of day.

What a wonderful chat board this weekend, many thanks to all.

Damn what a wine does! .4 again seems to be popular so 1.9%

Red is .6% I think so 2.1% declared I think, someone double check had a wine with supper. cheers

Completely get you red and well done Ryan for sharing... I did share one post one time a couple of weeks ago with a board I am active on I would be delighted if one person got in early from it.

Ryan, you said exactly the point I find so fascinating about investing. Pre RNS I measured the risk/reward here was worth 25K and I had a 5K top up post RNS so obviously my average is higher than yours at just over 5p. Now what do I have at risk here...30K. I am in profit so what is my risk if the SP doubles...30K, what is my risk if the SP halves 30K. That's why I am not trading as I made this decision a long time ago and if anything the conviction in my decision has got stronger and warrants a higher stake to be added but I don't as a rule. It's fascinating how numbers can skew our judgement. I am steadfast and if I am wrong then so be it there are other opportunities but one day I hope I choose correct. Come on IQAI :-)

Ryan that's where so much of us have been with decision making, the question is do you think this is different and demand is there. Don't look at past performance to predict the future forget stonechecker and the last trading pattern and look at the new product and the significant ground covered since. This is in a different play park now but I think you understand that as you held half your position.

Teleradiology and Expanding Distribution

Since the inception of IQ-AI's subsidiary, Imaging Biometrics™, LLC ("IB, the foundational architectural design strategy of the products has been to build them as platform independent plugins. Steadfast in this approach, IB has successfully translated advanced technologies into portable clinical solutions that readily extend the base functionality of established workstations, medical viewing stations, PACS, and servers. A logical application of the platform-independent design of IB's products is in telehealth. With the onset of Covid-19, healthcare providers had to find new ways to stay connected with patients and administer care. The field of telehealth is exploding and is, for all intents and purposes, and untapped market. During the review period, three licenses of IB Neuro were deployed specifically in teleradiology application. While IB's current products readily lend themselves as natural value-add extensions to established teleradiology platforms, the Company is exploring more direct applications and platforms in the rapidly emerging telehealth space.



In addition, IB entered into a new and enhanced partnership with CorTechs Labs "CorTechs". CorTechs is a privately held company which specialises in providing software to neuroradiologists to monitor neuro degenerative diseases like Alzheimer's. In 2019, the Company entered into a reseller agreement. As this relationship matured, both companies recognised the complementary and natural fit of IB products within the CorTechs platform. Thus, during the review period, the IB product line was embedded within the CorTechs application and now offers existing and new clients the distinct advantage of immediate accessibility to IB products in a streamlined and seamless workflow.



More recently, the IB product portfolio was made accessible via the Arterys AI marketplace. Arterys is an international company that offers a leading web-based (cloud), AI-powered platform on which the entire IB product line is available for trial or purchase. Training on the technology and clinical application for US sales and marketing teams was recently completed, and Arterys has started presenting IB solutions to prospective clients.

we are both roughly .4% each

0.8% so far add your total if you wish and re-post, thanks